StonvexLoading…
StonvexStonvexStonvexCore line items from ACNB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $191.82M | $132.19M | $115.08M | $108.86M |
Operating Income | $46.45M | $40.42M | $39.85M | $44.95M |
Net Income | $37.05M | $31.85M | $31.69M | $35.75M |
EPS (Diluted) | $3.60 | $3.73 | $3.71 | $4.15 |
Total Assets | $3.23B | $2.39B | $2.42B | $2.53B |
Total Liabilities | $2.81B | $2.09B | $2.14B | $2.28B |
Cash & Equivalents | $65.65M | $47.26M | $65.96M | $168.16M |
Free Cash Flow OCF − CapEx | $52.57M | $38.82M | $39.43M | $37.39M |
Shares Outstanding | 10.37M | 8.55M | 8.51M | 8.52M |